Refine by
Injectable Product Articles & Analysis
26 news found
The total value of the contract, including options to continue supplying the product until 2029, is up to $220 million. “We are humbled by the opportunity to support the U.S. government to enhance its readiness and preparedness to protect the U.S. civilian population and provide peace-of-mind to the emergency first responders if they have to use these ...
“The assessment of a booster injection in the patient population with HLA DR3-DQ2 will provide valuable information about the potential to prolong or reinforce the effect on the preservation of the body’s own insulin production. ...
It will also allow Aktiv to communicate with the FDA to create alignment on regulatory, technical, and scientific matters associated with gaining regulatory approvals for Aktiv’s products. “We are excited to participate in this important program and delighted that our technology was recognized by the Agency for its broad potential to improve quality and safety of ...
Fosun Pharma has been authorized by Neovii to exclusively sell and develop its immunosuppressant Grafalon ® (anti-human T cell rabbit immunoglobulin injection, hereinafter referred to as the "cooperative product") in China, Hong Kong, Macao and Taiwan. According to the agreement, Fosun Pharma will pay Neovii sales agency royalties and payments based on ...
Government to develop yet another one of the critically important emergency treatment products” said the company founder and CEO, Amir Genosar. “This award will help Aktiv continue advancing the TXA autoinjector towards FDA approval in 2025, which will ultimately be used to help protect both our troops and the civilian ...
This new type of prefilled injector will be ApiJect’s first product submitted for regulatory review and approval. The Prefilled ApiJect Injector and its manufacturing process include: An aseptically filled single-dose container, designed to enable efficient and intuitive injection administration. ...
’ What form does your product come in? F.B.: ‘In the form of a gel that is injected using a syringe, for arthritis and skin. ...
The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. ...
(OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce a non-brokered private placement financing (the “Offering”) of up to 8,333,333 units (each, a ...
Therefore, instead of offering in-stock products that were already manufactured, CD Formulation values more of the specific needs of each client. ...
“During the quarter, we continued to make progress on our product pipeline, with three new approvals – one in the U.S. and two in Europe. ...
ByBiocon
(OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce the filing of a new patent application covering novel aspects of the DermaPrecise™ ...
The Company’s product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. ...
The Company’s product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. ...
The product is developed, manufactured, and injected to regenerate the extracellular matrix under aging and/or sun-damaged skin characterized by fine wrinkles and loss of collagen structure. ...
Beyond Beauty Live will take place at the Business Design Centre in London’s trendy Islington on 7 & 8 May 2022 and will feature all there is to know about injectables, skincare, energy devices, cosmetic surgery, wellness and more. ...
A vaccine antigen (a foreign substance, usually a protein, that induces an immune response) is introduced into the body (most often via an injection), with the intention of stimulating the production of antibodies helpful in fighting off future illness. ...
We develop plastic injection moulds in the context of the Coronavirus epidemic (covid-19), these moulds make it possible to inject products locally and thus meet the needs of the personnel to be protected. ...
Methotrexate tablets are generic version of Dava Pharmaceuticals’ Rheumatrex Tablets. The product will be launched in March 2020. The approved product has an estimated market size of US$ 98 million for the twelve months ending December 2019, according to IQVIA. This is the 9 th ANDA (including 1 tentative approval) to be approved out of Eugia formulation ...
(Sofregen), an early stage commercial biotechnology company developing products for medical aesthetics and reconstructive surgery, announced today that Silk Voice has been cleared by the U.S. ...